(HealthDay News) – Vertebral compression fracture (VCF) is a common adverse effect in patients receiving spine stereotactic body radiotherapy (SBRT), according to research published online Aug. 19 in the Journal of Clinical Oncology.
In an effort to assess the risk and predictive factors associated with VCF, Arjun Sahgal, MD, of the University of Toronto, and colleagues analyzed data from 252 patients with a total of 410 spinal segments treated with SBRT.
The researchers found 57 VCFs in 410 spinal segments (14%), which included new fractures (47%) and fracture progression (53%). About 65% of the fractures occurred within the first four months, and the median time to fracture was 2.46 months (range, 0.03–43.01 months). Risk of VCF increased with increasing dose per fraction, with the highest risk for ≥24Gy vs. 20–23Gy vs. ≤19Gy. Three of the six criteria in the Spinal Instability Neoplastic Scoring System – baseline VCF, lytic tumor, and spinal deformity – were significant predictors of VCF.
“Caution must be observed when treating with ≥20Gy/fraction, in particular, for patients with lytic tumor, spinal misalignment, and a baseline VCF,” the authors write. “Frequent short-term follow-up is required, as nearly two-thirds of all VCF occurred within the first four months.”
Two authors disclosed financial ties to the medical technology industry.